Hi-Tech Pharmacal Receives Final Approval For Dorzolamide And Timolol Ophthalmic Solution

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the U.S. Food and Drug Administration (FDA) granted final approval to the Company’s Abbreviated New Drug Application (ANDA) for dorzolamide and timolol ophthalmic solution, the generic for Merck’s Cosopt® which had sales of $342 million for the 12 months ended June 2008 according to IMS.

More: continued here

Filed under: Eye Health on October 29th, 2008